English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
 
 
DownloadE-Mail
  RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state.

Belenguer, G., Mastrogiovanni, G., Pacini, C., Hall, Z., Dowbaj, A., Arnes-Benito, R., et al. (2022). RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state. Nature communications, 13(1): 334. doi:10.1038/s41467-021-27923-z.

Item is

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Belenguer, German, Author
Mastrogiovanni, Gianmarco, Author
Pacini, Clare, Author
Hall, Zoe, Author
Dowbaj, Anna1, Author           
Arnes-Benito, Robert, Author
Sljukic, Aleksandra, Author
Prior, Nicole, Author
Kakava, Sofia, Author
Bradshaw, Charles R.1, Author           
Davies, Susan E, Author
Vacca, Michele, Author
Saeb-Parsy, Kourosh, Author
Koo, Bon-Kyoung, Author
Huch, Meritxell1, Author           
Affiliations:
1Max Planck Institute for Molecular Cell Biology and Genetics, Max Planck Society, ou_2340692              

Content

show
hide
Free keywords: -
 Abstract: RNF43/ZNRF3 negatively regulate WNT signalling. Both genes are mutated in several types of cancers, however, their contribution to liver disease is unknown. Here we describe that hepatocyte-specific loss of Rnf43/Znrf3 results in steatohepatitis and in increase in unsaturated lipids, in the absence of dietary fat supplementation. Upon injury, Rnf43/Znrf3 deletion results in defective hepatocyte regeneration and liver cancer, caused by an imbalance between differentiation/proliferation. Using hepatocyte-, hepatoblast- and ductal cell-derived organoids we demonstrate that the differentiation defects and lipid alterations are, in part, cell-autonomous. Interestingly, ZNRF3 mutant liver cancer patients present poorer prognosis, altered hepatic lipid metabolism and steatohepatitis/NASH signatures. Our results imply that RNF43/ZNRF3 predispose to liver cancer by controlling the proliferative/differentiation and lipid metabolic state of hepatocytes. Both mechanisms combined facilitate the progression towards malignancy. Our findings might aid on the management of those RNF43/ZNRF3 mutated individuals at risk of developing fatty liver and/or liver cancer.

Details

show
hide
Language(s):
 Dates: 2022-01-17
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Identifiers: DOI: 10.1038/s41467-021-27923-z
Other: cbg-8268
PMID: 35039505
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Nature communications
  Other : Nat Commun
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 13 (1) Sequence Number: 334 Start / End Page: - Identifier: -